ESC 2024 | The OCCUPI Trial: Guided PCI for OCT in Complex Lesions

The aim of this stud was to compare the clinical benefits of OCT guided PCI (optical coherence tomography) vs angiography guided PCI, when assessing major cardiovascular events (MACE) at one year. 

The study recruited 1,604 patients undergoing DES stenting for complex coronary anatomy. Patients were randomized 1:1. Mean age was 64, 80% were men and 49% had been diagnosed with acute coronary syndrome. 

OCT allowed using stents with larger diameters (3.2 mm vs 3.0 mm; P<0.001), lower residual stenosis (12.0% vs 14.0%; P<0.001) and larger minimal luminal diameter (2.75 mm vs 2.59 mm; P<0.001).

As regards the primary end point of MACE at one year, it was 4.6% in among OCT patients and 7.4% for angiography, which represented an absolute reduction of 2.8% (HR 0.62; CI95% 0.41-0.93; P=0.023). When looking at secondary events, there were significant differences with higher incidence of spontaneous acute MI and reduced need for new target vessel revascularization. 

Read also: ESC 2024 | SCOFF Trial: Fasting or No Fasting before Cardiac Catheterization Procedures.

The study also classified patients according to whether the angiography had been optimized or not, using three criteria: adequate stent expansion, good apposition, and absence of edge dissection. Those with optimized angiography presented a 77% reduction in events vs. patients with suboptimal outcomes (HR 0.33; CI95% 0.17-0.65; P=0.001).

This multicenter study showed that OCT guided treatment of complex coronary lesions resulted in lower incidence of adverse events such as cardiac mortality, AMI, stent thrombosis, and need for new revascularization at one year. 

Presented by Byeong-Keuk Kim at the Hot-Line Sessions, ESC Congress 2024, August 30 thru September 2, London, England 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...